Latest Research News

Home / Latest Research News
First treatment licensed for primary progressive MS in the US
Ocrelizumab has been approved as a treatment for both relapsing and primary progressive MS in the US. It is the
Read more.
French Conference
Top neurologists from the world of science and medicine showcased developments in MS research at the 26th annual conference of
Read more.
Follow by Email